TABLE 1.

The relationship between miR-30d-5p expression and clinical characteristics in multiple cancers.

Cancer type	Property	Studied species and biomaterial	Expression	Prognosis	Number of cases	Refs
Lung cancer	Suppressor	Human tumorous tissue	Down	Favorable	24	Hosseini et al. (2018)
	Oncogene	NSCLC cell lines and body fluid	Down	Poor	—	Li et al. (2017)
	Suppressor	Human NSCLC tissue and cell lines	Down	Favorable	80	Zeng et al. (2020)
	—	HEK 293T cells	Down	—	—	Chen et al. (2015)
	—	Human NSCLC tissue and cell lines	Down	—	—	Gao et al. (2018)
	Suppressor	Human NSCLC tissue	Down	Favorable	81	Zhang et al. (2017)
	Suppressor	Human LUSC cell lines	Down	Favorable	—	Qi et al. (2021)
	Suppressor	Human LUAD tissue and cell lines	Down	Favorable	20	Zhao et al. (2021)
	Suppressor	Human NSCLC cell lines	Down	—	—	Chen et al. (2021)
Gallbladder carcinoma	Suppressor	Human GBC tissue and cell lines	Down	Favorable	53	He et al. (2018)
Cholangiocarcinoma	Oncogene	Human bile and serum	Up	Poor	106	Han et al. (2020a)
Rectal cancer	—	Human CRC tissue and cell lines	Down	—	—	Bjørnetrø et al. (2019)
Colon cancer	—	Human tumorous tissue	—	—	396	Jacob et al. (2017)
	Suppressor	Human tumorous tissue and cell lines	Down	Favorable	60	Yu et al. (2018)
Prostate cancer	Suppressor	Human PCa tissue and PC cell lines	Down	Favorable	40	Song et al. (2018)
	—	Human PCa cell lines	Down	—	—	Kumar et al. (2016)
	—	Human seminal fluid and PCa cell lines	Down	Favorable	24	Barceló et al. (2020)
Esophageal squamous cell carcinoma	—	Human serum	Up	Poor	30	Zhu et al. (2017)
	Suppressor	Human ESCC tissue and cell lines	Down	Favorable	144	Guo et al. (2021)
	Suppressor	Human ESCC tissue and cell lines	Down	Favorable	64	Wang et al. (2020)
Ovarian cancer	Suppressor	The meta-analysis	Down	Favorable	—	Shi et al. (2018)
Cervical cancer	—	Human tumorous tissue	Down	Favorable	121	Zheng et al. (2019)
Breast cancer	—	Human tumorous tissue	Down	Favorable	96	Kunc et al. (2020)
Renal cell carcinoma	Suppressor	Human RCC tissue and cell lines	Down	Favorable	25	Liang et al. (2021)
Pancreatic cancer	Suppressor	Pancreatic cancer cell	Down	Favorable	—	Zheng et al. (2021)
Osteosarcoma	Oncogene	Human cell line HFOB1.19	Up	Poor	—	Hu Y. et al. (2021)
Thyroid cancer	Suppressor	Cell lines	Down	—	—	Hu C. et al. (2021)
Hepatocellular carcinoma	Suppressor	Human HCC tissue	Down	Favorable	36	Yu et al. (2019)
	Suppressor	Human HCC tissue and cell lines	Down	Favorable	25	Zhuang et al. (2019)